News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Regado Biosciences Downsizes IPO, Seeks $42 Million


8/20/2013 7:52:51 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Apparently not everyone is having success pitching a biotech IPO to investors these days. Basking Ridge, NJ-based Regado Biosciences, the startup developing a two-pronged anticoagulant to be used in coronary procedures, is slashing the price of its IPO considerably. Regado initially aimed to raise $75 million by offering investors 5 million shares at between $14 and $16 apiece.

Help employers find you! Check out all the jobs and post your resume.

Read at Xconomy

comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES